Central blood pressure reflects left ventricular load, while brachial blood pressure reflects arterial damage

References

• Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet. 2003;362: 1527–1535.
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Lehmann MV, Schmidt S. Optimizing blood pressure control in hypertension: The need to use ABPM. Blood Press. 2013;22:65–72.
   Web of Science ®Google Scholar
• Prospective Studies Collaboration. Age-specific relevance of usual BP to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913.
   PubMed Web of Science ®Google Scholar
• Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al.; CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113: 1213–1225.
   PubMed Web of Science ®Google Scholar
• Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: The Strong Heart Study. Hypertension. 2007;50:197–203.
   PubMed Web of Science ®Google Scholar
• Wang KL, Cheng HM, Chuang SY, Spurgeon HA, Ting CT, Lakatta EG, et al. Central or peripheral systolic or pulse pressure: Which best relates to target organs and future mortality? J Hypertens 2009;27:461–467.
   PubMed Web of Science ®Google Scholar
• Masugata H, Senda S, Okuyama H, Murao K, Inukai M, Hosomi N, et al. Comparison of central blood pressure and cardio-ankle vascular index for association with cardiac function in treated hypertensive patients. Hypertens Res. 2009;32:1136–1142.
   PubMed Web of Science ®Google Scholar
• Huang CM, Wang KL, Cheng HM, Chuang SY, Sung SH, Yu WC, et al. Central versus ambulatory blood pressure in the prediction of all-cause and cardiovascular mortalities. J Hypertens. 2011;29:454–459.
   PubMed Web of Science ®Google Scholar
• O’Rourke M. Mechanical principles in arterial disease. Hypertension. 1995;26:2–9.
   PubMed Web of Science ®Google Scholar
• Mitchell GF, Lacourcière Y, Ouellet JP, Izzo JL Jr, Neutel J, Kerwin LJ, et al. Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: The role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation. 2003;108: 1592–1598.
   PubMedGoogle Scholar
• Izzo JL Jr. Arterial stiffness and the systolic hypertension syndrome. Curr Opin Cardiol. 2004;19:341–352.
   PubMed Web of Science ®Google Scholar
• Takazawa K, Tanaka N, Takeda K, Kurosu F, Ibukiyama C. Underestimation of vasodilator effects of nitroglycerin by upper limb blood pressure. Hypertension. 1995;26: 520–523.
   PubMed Web of Science ®Google Scholar
• Pauca AL, O’Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001; 38:932–937.
   PubMed Web of Science ®Google Scholar
• O’Rourke MF, Nichols WW. Potential for use of pulse wave analysis in determining the interaction between sildenafil and glyceryl trinitrate. Clin Cardiol. 2002;25:295–299.
   Google Scholar
• Gallagher D, Adji A, O’Rourke MF. Validation of the transfer function technique for generating central from peripheral upper limb pressure waveform. Am J Hypertens. 2004;17: 1059–1067.
   PubMed Web of Science ®Google Scholar
• Hirata K, Vlachopoulos C, Adji A, O’Rourke MF. Benefits from angiotensin-converting enzyme inhibitor ‘beyond blood pressure lowering’: Beyond blood pressure or beyond the brachial artery?J Hypertens. 2005;23:551–556.
   PubMed Web of Science ®Google Scholar
• Takazawa K, Kobayashi H, Shindo N, Tanaka N, Yamashina A. Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave. Hypertens Res. 2007;30:219–228.
   PubMed Web of Science ®Google Scholar
• Takase H, Dohi Y, Kimura G. Distribution of central blood pressure values estimated by Omron HEM-9000AI in the Japanese general population. Hypertens Res. 2013;36:50–57.
   PubMed Web of Science ®Google Scholar
• Hickson SS, Butlin M, Mir FA, Graggaber J, Cheriyan J, Khan F, et al. Anglo-Cardiff Collaboration Trial Investigators. The accuracy of central SBP determined from the second systolic peak of the peripheral pressure waveform. J Hypertens. 2009;27:1784–1788.
   PubMed Web of Science ®Google Scholar
• Takazawa K, Kobayashi H, Kojima I, Aizawa A, Kinoh M, Sugo Y, et al. Estimation of central aortic systolic pressure using late systolic inflection of radial artery pulse and its application to vasodilator therapy. J Hypertens. 2012;30: 908–916.
   PubMed Web of Science ®Google Scholar
• Agabiti-Rosei E, Mancia G, O’Rourke MF, Roman MJ, Safar ME, Smulyan H, et al. Central blood pressure measurements and antihypertensive therapy: A consensus document. Hypertension. 2007;50:154–160.
   PubMed Web of Science ®Google Scholar
• Matsui Y, Eguchi K, O’Rourke MF, Ishikawa J, Miyashita H, Shimada K, et al. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension. 2009;54:716–723.
   PubMed Web of Science ®Google Scholar
• Boutouyrie P, Achouba A, Trunet P, Laurent S; EXPLOR Trialist Group. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: The EXPLOR study. Hypertension. 2010;55:1314–1322.
   PubMed Web of Science ®Google Scholar
• Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.J Clin Invest. 1991;87: 1402–1412.
   PubMed Web of Science ®Google Scholar
• Hirata Y, Matsumoto A, Aoyagi T, Yamaoki K, Komuro I, Suzuki T, et al. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. Cardiovasc Res. 2001;51:585–591.
   PubMedGoogle Scholar
• Takase H, Toriyama T, Sugiura T, Takahashi A, Sugiyama M, Ohashi M, et al. Brain natriuretic peptide detects cardiac abnormalities in mass screening. Eur J Clin Invest. 2007;37:257–262.
   Google Scholar
• Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, et al. Human brain natriuretic peptide, a novel cardiac hormone. Lancet. 1990;335:801–802.
   PubMedGoogle Scholar
• Buckley MG, Markandu ND, Miller MA, Sagnella GA, MacGregor GA. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens. 1993;7:245–250.
   PubMedGoogle Scholar
• Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci (Lond). 1998;95:519–529.
   PubMed Web of Science ®Google Scholar
• Jakubik P, Janota T, Widimsky J Jr, Zelinka T, Strauch B, Petrak O, et al. Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration. Blood Press. 2006;15:302–307.
   PubMed Web of Science ®Google Scholar
• de Luca N, Asmar RG, London GM, O’Rourke MF, Safar ME; REASON Project Investigators. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens. 2004;22:1623–1630.
   PubMed Web of Science ®Google Scholar
• Edwards DG, Gauthier AL, Hayman MA, Lang JT, Kenefick RW. Acute effects of cold exposure on central aortic wave reflection. J Appl Physiol. 2006;100:1210–1214.
   Google Scholar
• Wojciechowska W, Stolarz-Skrzypek K, Tikhonoff V, Richart T, Seidlerová J, Cwynar M, et al.; European Project On Genes In Hypertension (Epogh) Investigators. Age dependency of central and peripheral systolic blood pressures: Cross-sectional and longitudinal observations in European populations. Blood Press. 2012;21:58–68.
   PubMed Web of Science ®Google Scholar
• Dart AM, Cameron JD, Gatzka CD, Willson K, Liang YL, Berry KL, et al. Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension. 2007;49:1242–1247.
   Google Scholar
• Hope SA, Antonis P, Adam D, Cameron JD, Meredith IT. Arterial pulse wave velocity but not augmentation index is associated with coronary artery disease extent and severity: Implications for arterial transfer function applicability. J Hypertens. 2007;25:2105–2109.
   PubMedGoogle Scholar
• Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: A systematic review and meta-analysis. Eur Heart J. 2010;31:1865–1871.
   PubMed Web of Science ®Google Scholar
• Richardson CJ, Maki-Petaja KM, McDonnell BJ, Hickson SS, Wilkinson IB, McEniery CM. Comparison of estimates of central systolic blood pressure and peripheral augmentation index obtained from the Omron HEM-9000AI and SphygmoCor systems. Artery Res. 2009;3:24–31.
   Google Scholar